Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Levitt Insider Profile
4 Followers
Daniel Levitt, EVP and Chief Medical Officer at LadRx, holds 0.00 shares in Neurogene (Ticker: NGNE), holds 214.29K shares in LadRx (Ticker: LADX), holds 16.67K shares in Dynavax (Ticker: DVAX).
Daniel Levitt has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Levitt holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel Levitt
Daniel Levitt's Trading History
LadRx
Jan 03, 2014
EVP and Chief Medical Officer
Uninformative Buy
―
$447.86K
Neurogene
May 16, 2018
Director
Uninformative Buy
41.25K
$0.00
Dynavax
―
VP
―
$191.49K
Sorrento Therapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Daniel Levitt's performance on stock
You May Also Like
Daniel Levitt insider profile FAQ
What is the percentage of profitable transactions made by Daniel Levitt?
The percentage of profitable transactions made by Daniel Levitt is ―.
What is the average return per transaction made by Daniel Levitt?
The average return per transaction made by Daniel Levitt is ―.
What stocks does Daniel Levitt hold?
Daniel Levitt holds: LADX, NGNE, DVAX, SRNE stocks.
What was Daniel Levitt’s latest transaction?
Daniel Levitt latest transaction was an Uninformative Buy of $41.25K.
What was Daniel Levitt's most profitable transaction?
Daniel Levitt’s most profitable transaction was an Informative Sell of NGNE stock on May 16, 2018. The return on the trade was 79.40%.
What is Daniel Levitt's role in LadRx?
Daniel Levitt's role in LadRx is EVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.